Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Lane

Showing results (71-80 of 265) with videos related to

Pageof 27
Sort By:
Journal of Chronic Diseases|January 1, 1987
Analgesic use, blood dyscrasias, and case-control pharmacoepidemiology. A critique of the International Agranulocytosis and Aplastic Anemia StudyM S Kramer, D A Lane, T A Hutchinson
Biochimica Et Biophysica Acta|September 17, 1980
The heparin-accelerated neutralisation of bovine alpha and beta thrombins by antithrombin IIII R MacGregor, D A Lane, V V Kakkar
Thrombosis Research|October 1, 1976
Effect of dextran on clotting time: steric exclusion accelerates fibrin monomer polymerisationM W Rampling, D A Lane, V V Kakkar
International Journal of Clinical Practice|June 17, 2011
Bleeding risk with oral anticoagulation--new frontiers and new questionsA Banerjee, D A Lane, G Y H Lip
Biochemical Society Transactions|January 1, 1976
Effect of steric exclusion by dextran on the conversion of fibrinogen into fibrinM W Rampling, D A Lane, V V Kakkar
Thrombosis Research|May 1, 1977
Prolonged thrombin clotting times in liver diseaseD A Lane, M F Scully, V V Kakkar
Biochemical Society Transactions|January 1, 1978
The relationship between molecular weight and specific activity of unfractionated and fractionated heparins [proceedings]I R MacGregor, D A Lane, V V Kakkar
European Journal of Biochemistry|March 15, 1985
Thrombin-induced fibrinopeptide release from a fibrinogen variant (fibrinogen Sydney I) with an Aalpha Arg-16----His substitutionC Southan, D A Lane, W Bode, et al.
Biochimica Et Biophysica Acta|September 3, 1979
Evidence for a plasma inhibitor of the heparin accelerated inhibition of factor Xa by antithrombin IIII R MacGregor, D A Lane, V V Kakkar
Journal of Clinical Pharmacology|December 1, 1990
The Bayesian differential diagnosis of neutropenia associated with antiarrhythmic agentsC A Naranjo, K L Lanctôt, D A Lane
Pageof 27

Showing results (71-80 of 265) with videos related to

Sort By:
Pageof 27
Journal of Chronic Diseases|January 1, 1987
Analgesic use, blood dyscrasias, and case-control pharmacoepidemiology. A critique of the International Agranulocytosis and Aplastic Anemia StudyM S Kramer, D A Lane, T A Hutchinson
Biochimica Et Biophysica Acta|September 17, 1980
The heparin-accelerated neutralisation of bovine alpha and beta thrombins by antithrombin IIII R MacGregor, D A Lane, V V Kakkar
Thrombosis Research|October 1, 1976
Effect of dextran on clotting time: steric exclusion accelerates fibrin monomer polymerisationM W Rampling, D A Lane, V V Kakkar
International Journal of Clinical Practice|June 17, 2011
Bleeding risk with oral anticoagulation--new frontiers and new questionsA Banerjee, D A Lane, G Y H Lip
Biochemical Society Transactions|January 1, 1976
Effect of steric exclusion by dextran on the conversion of fibrinogen into fibrinM W Rampling, D A Lane, V V Kakkar
Thrombosis Research|May 1, 1977
Prolonged thrombin clotting times in liver diseaseD A Lane, M F Scully, V V Kakkar
Biochemical Society Transactions|January 1, 1978
The relationship between molecular weight and specific activity of unfractionated and fractionated heparins [proceedings]I R MacGregor, D A Lane, V V Kakkar
European Journal of Biochemistry|March 15, 1985
Thrombin-induced fibrinopeptide release from a fibrinogen variant (fibrinogen Sydney I) with an Aalpha Arg-16----His substitutionC Southan, D A Lane, W Bode, et al.
Biochimica Et Biophysica Acta|September 3, 1979
Evidence for a plasma inhibitor of the heparin accelerated inhibition of factor Xa by antithrombin IIII R MacGregor, D A Lane, V V Kakkar
Journal of Clinical Pharmacology|December 1, 1990
The Bayesian differential diagnosis of neutropenia associated with antiarrhythmic agentsC A Naranjo, K L Lanctôt, D A Lane
Pageof 27